Skip to content

Marzetti stock

MZTINASDAQ

The Marzetti Company, Consumer DefensiveISIN US5138471033

$110.53▼ $0.96 (−0.9%)Closing price of 12 Nov 2026

67Score 67 out of 100, Neutral

Turn on early warning

Price and trend

59 / 100

Price history

−37% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 9.4% below it.

Trend change

Since October 2025 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 53).

Distance to the high

The price is 37% below its 52-week high. Largest decline in 20 years: 55% (May 2023 to September 2026).

Chart figures for advanced users
SMA 50$104.41
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$122.06
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)53
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$99.19
The lowest closing price of the last twelve months.
Resistance$174.10
The highest closing price of the last twelve months.
Market cap
$3.04B
Div. yield
3.59%
12 months
17.5
Fair value
$120.37

Snapshot

Computed from the data by fixed rules, no AI

  • The Marzetti Company belongs to the Packaged Foods industry (United States) and, with a market value of $3.01B, is number 47 of 75 companies in its industry on MEQIRI.
  • In fiscal 2026 it reported revenue of $1.93B (up 1.1% year on year) and earnings of $191.61M (up 14.5%).
  • For fiscal 2027, analysts expect on average revenue of $2B (up 3.6%) and adjusted earnings per share of $6.56 (down 4.5%).
Show more
  • MEQIRI Score 67 out of 100 (Neutral): rank 104 of 295 in Consumer Defensive, median 62.
  • The P/E is 17.3 (Packaged Foods median 18.7, own median of recent years 30.1).
  • Our model puts fair value at $120.37, with the price 7% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Reliable dividendNo dividend cut for 39 years.Capital allocation 74
  • Consistently profitableProfit in all 10 fiscal years from 2017 to 2026.Fundamentals 90
  • High return on capitalReturn on invested capital 21.2% in fiscal 2026, Packaged Foods median 7.3%.Profitability 66

Weaknesses

  • Share price fell sharplyDown 36% over the last 12 months.Momentum 43
67/ 100
MEQIRI Score
Neutral

Its standout strengths are fundamentals and stability, while momentum holds the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 66 to 67.

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)107%
ROIC (12 months)17.9%
Positive free cash flow90% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • price far below its 52-week high

What lowers it

  • solid fundamentals

Valuation

Valuation signal

Fairly valued
Price
$111.49
Fair value
$120.37
Gap to fair value
−7%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $92.59 and expensive above $171.95 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $121.75 (cash-flow model) and $118.98 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is slightly below both parts; given how much the stock swings, that still counts as fair.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $110.52, at 7.8% it would be $135.12.

Valuation metrics

3.28
10.9
Fair value (model)
$120.37
Earnings part $118.98 (earnings per share $6.37 × 18.7)

Half from the cash-flow model, half from earnings times the industry P/E (18.7).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue fell 0.9% on the twelve months before. Revenue has grown solidly since 2007, at about 3% per year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2026: gross 25%, operating 12%, net 10%.

Debt & balance sheet

latest quarter
0.22
> 100x
1.53
Cash & equivalents
$17.52M

The balance sheet is solid, with low debt and comfortable interest coverage.

Earnings

Next earnings
2 Feb 2027in 82 days
Last reported
3 Nov 2026EPS reported $1.14 (expected $1.37)below expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20274 analysts
Earnings per share
$6.56−2.2%
Revenue
$2B−0.1%
Fiscal 20286 analysts
Earnings per share
$7.16−0.9%
Revenue
$2.05B+0.2%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: −2.0%

First outlook for fiscal 2027: gross margin up about 1 percentage point and tax rate of 23%; in the first quarter an outbreak is expected to cut net sales by about 2.5 percentage points.

Supporting passage from the call, verbatim
“Given the Cyclospora impact, we do expect you know, the impact on revenue on the base business that David highlighted Which gets us into kind of flattish net sales in Q1. We do not expect to be able to grow our margins in the first quarter.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 25 Aug 2026 (fiscal Q4 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

One insider bought on the open market in the last 6 months, $98,109 in total. One insider sold, $233,980 in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Viso LuisSale

    10 Sept 2026, Strategic Advisor to CEO

    Shares
    997
    Price
    $100.81
    Value
    $100,512
  • Viso LuisSale

    11 Jun 2026, Chief Supply Chain Officer

    Shares
    1,221
    Price
    $109.31
    Value
    $133,468
  • Pigott, Thomas K.Purchase

    10 Jun 2026, VP, CFO and Asst. Secretary

    Shares
    900
    Price
    $109.01
    Value
    $98,109

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Marzetti

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

295 rated companies in Consumer Defensive

Rank 104 of 295
104/ 295
This company
67
Sector median
62

Categories against the sector median

ProfitabilityMedian of 295 companies66 (median 54)12 above the median
GrowthMedian of 295 companies55 (median 50)5 above the median
FundamentalsMedian of 295 companies90 (median 79)11 above the median
ValuationMedian of 290 companies with a value60 (median 65)5 below the median
StabilityMedian of 295 companies85 (median 68)17 above the median
Capital allocationMedian of 295 companies74 (median 62)12 above the median
Technical analysisMedian of 295 companies59 (median 65)6 below the median
MomentumMedian of 295 companies43 (median 60)17 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Packaged Foods

The next larger and next smaller companies by market value

All 75 Packaged Foods stocks

ETFs that hold Marzetti

Held by 5 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 2 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2026, period end 30 Jun 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 27 Feb 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy